• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Apremilast in Paediatric Dermatoses - A Comprehensive Review.阿普米司特治疗儿童皮肤病——全面综述
Indian J Dermatol. 2022 Mar-Apr;67(2):206. doi: 10.4103/ijd.ijd_482_21.
2
On- and Off-Label Uses of Apremilast in Dermatology.阿普米司特在皮肤科的适应证内和适应证外使用。
Acta Dermatovenerol Croat. 2020 Dec;28(3):171-179.
3
Apremilast in the Treatment of Plaque Psoriasis: Differential Use in Psoriasis.阿普米拉斯治疗斑块状银屑病:在银屑病中的差异应用
Clin Cosmet Investig Dermatol. 2022 Mar 8;15:395-402. doi: 10.2147/CCID.S266036. eCollection 2022.
4
The Use of Apremilast in Psoriasis: A Delphi Study.阿普米司特治疗银屑病的应用:德尔菲研究。
Actas Dermosifiliogr (Engl Ed). 2020 Mar;111(2):115-134. doi: 10.1016/j.ad.2019.07.005. Epub 2019 Dec 19.
5
Apremilast in dermatology: A review of literature.阿普米司特在皮肤科的应用:文献综述。
Dermatol Ther. 2020 Nov;33(6):e14261. doi: 10.1111/dth.14261. Epub 2020 Sep 27.
6
Off-label studies on apremilast in dermatology: a review.阿普斯特在皮肤科的超适应证研究:综述。
J Dermatolog Treat. 2020 Mar;31(2):131-140. doi: 10.1080/09546634.2019.1589641. Epub 2019 Apr 2.
7
Comparison of psoriasis guidelines for use of apremilast in the United States and Europe: a critical appraisal and comprehensive review.比较美国和欧洲的阿普米司特治疗银屑病指南:批判性评价和全面综述。
J Dermatolog Treat. 2022 Feb;33(1):94-99. doi: 10.1080/09546634.2020.1770176. Epub 2020 May 25.
8
Pharmacokinetics and safety of apremilast in pediatric patients with moderate to severe plaque psoriasis: Results from a phase 2 open-label study.阿普米司特在中重度斑块状银屑病儿科患者中的药代动力学和安全性:来自一项 2 期开放标签研究的结果。
J Am Acad Dermatol. 2020 Feb;82(2):389-397. doi: 10.1016/j.jaad.2019.08.019. Epub 2019 Aug 10.
9
Comparison of the Efficacy and Safety of Apremilast and Methotrexate in Patients with Palmoplantar Psoriasis: A Randomized Controlled Trial.阿普米司特与甲氨蝶呤治疗掌跖脓疱病患者的疗效和安全性比较:一项随机对照试验。
Am J Clin Dermatol. 2021 May;22(3):415-423. doi: 10.1007/s40257-021-00596-6. Epub 2021 Mar 12.
10
Apremilast for the treatment of moderate-to-severe palmoplantar psoriasis: results from a double-blind, placebo-controlled, randomized study.阿普米司特治疗中重度掌跖银屑病:一项双盲、安慰剂对照、随机研究的结果。
J Eur Acad Dermatol Venereol. 2018 Mar;32(3):403-410. doi: 10.1111/jdv.14647. Epub 2017 Nov 15.

本文引用的文献

1
The Use of Apremilast in Psoriasis: An Indian Perspective on Real-World Scenarios.阿普米拉斯在银屑病治疗中的应用:印度对现实世界情况的看法。
Psoriasis (Auckl). 2021 Aug 14;11:109-122. doi: 10.2147/PTT.S320810. eCollection 2021.
2
Apremilast in dermatology: A review of literature.阿普米司特在皮肤科的应用:文献综述。
Dermatol Ther. 2020 Nov;33(6):e14261. doi: 10.1111/dth.14261. Epub 2020 Sep 27.
3
COVID-19 patients with psoriasis and psoriatic arthritis on biologic immunosuppressant therapy vs apremilast in North Spain.西班牙北部接受生物免疫抑制剂治疗的 COVID-19 合并银屑病和银屑病关节炎患者与接受阿普米司特治疗患者的比较。
Dermatol Ther. 2020 Nov;33(6):e13961. doi: 10.1111/dth.13961. Epub 2020 Jul 27.
4
Systemic or biologic treatment in psoriasis patients does not increase the risk of a severe form of COVID-19.银屑病患者接受全身治疗或生物治疗不会增加患重症 COVID-19 的风险。
J Eur Acad Dermatol Venereol. 2020 Nov;34(11):e676-e679. doi: 10.1111/jdv.16761. Epub 2020 Jul 9.
5
Clinical efficacy, speed of improvement and safety of apremilast for the treatment of adult Psoriasis during COVID-19 pandemic.阿普米司特治疗 COVID-19 大流行期间成人银屑病的临床疗效、改善速度和安全性。
Dermatol Ther. 2020 Jul;33(4):e13722. doi: 10.1111/dth.13722. Epub 2020 Jun 24.
6
Apremilast as a potential treatment option for COVID-19: No symptoms of infection in a psoriatic patient.阿普司特作为治疗新冠肺炎的潜在选择:一名银屑病患者无感染症状。
Dermatol Ther. 2020 Jul;33(4):e13668. doi: 10.1111/dth.13668. Epub 2020 Jun 24.
7
Opportunistic virus infections in psoriasis patients: The safer alternative of apremilast in the COVID-19 era.银屑病患者的机会性病毒感染:在新冠疫情时代阿普米拉斯更安全的选择。
Dermatol Ther. 2020 Jul;33(4):e13618. doi: 10.1111/dth.13618. Epub 2020 Jun 4.
8
Steroid-resistant alopecia totalis in a child successfully treated with oral apremilast and platelet-rich plasma therapy.一名儿童的类固醇抵抗性全秃经口服阿普斯特和富血小板血浆疗法成功治疗。
Dermatol Ther. 2019 Nov;32(6):e13082. doi: 10.1111/dth.13082. Epub 2019 Sep 30.
9
Pharmacokinetics and safety of apremilast in pediatric patients with moderate to severe plaque psoriasis: Results from a phase 2 open-label study.阿普米司特在中重度斑块状银屑病儿科患者中的药代动力学和安全性:来自一项 2 期开放标签研究的结果。
J Am Acad Dermatol. 2020 Feb;82(2):389-397. doi: 10.1016/j.jaad.2019.08.019. Epub 2019 Aug 10.
10
Off-label studies on apremilast in dermatology: a review.阿普斯特在皮肤科的超适应证研究:综述。
J Dermatolog Treat. 2020 Mar;31(2):131-140. doi: 10.1080/09546634.2019.1589641. Epub 2019 Apr 2.

阿普米司特治疗儿童皮肤病——全面综述

Apremilast in Paediatric Dermatoses - A Comprehensive Review.

作者信息

Patro Nibedita, Panda Maitreyee, Dash Mrityunjay, Das Anupam

机构信息

Department of Skin and VD, Hi-Tech Medical College and Hospital, Utkal University, Bhubaneswar, Odisha, India.

Department of Skin and VD, IMS and SUM Hospital, SOA University, Bhubaneswar, Odisha, India.

出版信息

Indian J Dermatol. 2022 Mar-Apr;67(2):206. doi: 10.4103/ijd.ijd_482_21.

DOI:10.4103/ijd.ijd_482_21
PMID:36092227
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9455127/
Abstract

Apremilast has recently garnered attention in the management of multiple dermatological conditions including psoriasis. The comparable effectiveness with immunosuppressive drugs and a favorable side effect profile makes the drug, a prudent alternative for managing a gamut of dermatoses. In this article, we have reviewed the literature on apremilast use in children.

摘要

阿普米拉斯最近在包括银屑病在内的多种皮肤病管理中受到关注。与免疫抑制药物相当的疗效以及良好的副作用谱使该药物成为治疗多种皮肤病的明智选择。在本文中,我们回顾了有关阿普米拉斯在儿童中应用的文献。